Pandemic influenza vaccine H5N1 (AstraZeneca)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePandemic influenza vaccine H5N1 (AstraZeneca)
Drug Alias Name5N1 influenza vaccine (MedImmune/NIAID)H5N1禽流感疫苗 - MedImmune/NIAIDpandemic influenza vaccine (H5N1) (live attenuated, nasal)Avian flu vaccine (MedImmune/NIAID)Pandemic influenza vaccine (MedImmune/NIAID) +[7] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsVirus DiseasesInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2016/05/20
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca PlcNational Institute Of Allergy And Infectious Diseases (Niaid)Medimmune Llc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Ab
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsInfluenza, Human
Inactive IndicationsVirus Diseases

Other Information

ATC CodeJ07BB03
Related LinksN/A